Not Just 1 disease but 6 subtypes of Triple Negative Breast Cancer and identifying the different chemotherapies that they respond to:
- BL1 and BL2 - These 2 "basal-like" types relates to cell cycle and DNA response genes and responds to the drug, Cisplatin.
- M and MSL - These two "mesenchymal" types are driven by genes as it relates to cell differentiation and growth factor pathways that responds to the drug, Dasatinib and an experimental drug, NVP-BEZ235.
- IM - A "immunomodulatory" type as it relates to immune system genes.
- LAR - A "luminal" type relates to the "male" sex hormone, androgen signals and responds to the drug, Bicalutamide.